Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:01 May,2020

To free up care spaces, Maharashtra wants asymptomatic patients to be home

MUMBAI: Following central guidelines, the state government has directed that all asymptomatic positive patients going to private hospitals should be stamped and sent away for home quarantine after proper counselling.
The move is aimed at decongesting care centres since the state’s case load is just two short of 10,500. But the BMC, which is catering to 70% of the state’s Covid-19 patients, including those in Mumbai and its extended suburbs, says it is unlikely to implement the order immediately. Additional municipal commissioner Suresh Kakani said the city’s unique demographic and socio-economic challenges, like slum clusters, may not allow the BMC to adopt such a policy as yet, though it is being studied locally....read more


Its time to start de-locking: Seal 2 km of area around active and new cases and open areas with no new cases in the last 14 days

To
Sh Narendra Modi, Hon’ble Prime Minister of India
This is why, because now we know
1That lock down has given us enough prevention guidelines....read more


CMAAO Coronavirus Facts and Myth Buster 76

(With regular inputs from Dr Monica Vasudev)
Asymptomatic transmission has made controlling the spread of the disease all the more difficult
The requirement of PPEs:
In order to control the disease, even asymptomatic cases need to be tested in varied population settings such as prisons, mental health facilities, homeless shelters, hospitalized inpatients and other congregate living situations, argue researchers in an editorial published in the The New England Journal of Medicine (NEJM) on April 24....read more


Relieve Stress by Changing the Interpretation

Stress is the reaction of the body or the mind to the interpretation of a known situation. Stress management, therefore, involves either changing the situation, changing the interpretation or taming the body the yogic way in such a way that stress does not affect the body.
Every situation has two sides. Change of interpretation means looking at the other side of the situation. It is something like half glass of water, which can be interpreted as half empty or half full. ....read more


Video of The day

??? ??? ?? ????? ????? ???? ??


Health Sutras By Dr K K Aggarwal

Avoid routine visits to hospital


Medbytes

       


Healthcare News Monitor

India's Glenmark to conduct trials for potential COVID-19 drug, shares jump
India Today

Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month. "After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement https://reut.rs/2VNF43h. The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for a comment. On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

CSIR looks at repurposing common flu drug to treat corona
The Indian Express

The Council of Scientific and Industrial Research (CSIR) on Thursday announced that it has identified 25 drugs which can be repurposed to treat COVID-19 patients. While much-discussed drugs such as remdesivir (developed by Gilead Sciences and used to treat the Ebola virus) and Hydroxychloroquine (HCQ) already feature on the CSIR list, favipiravir, a broad spectrum inhibitor of viral RNA polymerase, has now emerged as of one of the most promising drugs, according to scientists at the Council. Drug repositioning is the process of redeveloping a compound for use in a different disease. Favipiravir was developed by Fujifilm Toyama Chemical Ltd, Japan, a subsidiary of Japan’s Fujifilm Corporation, and is an approved treatment for common influenza. The drug is marketed in Russia, China and Japan. Dr Geethavani Rayasam, senior principal scientist at CSIR, said, “From preliminary data, it has been seen that favipiravir seems to be effective in treating the COVID-19 virus. The drug is used to treat influenza and is already being used in Russia, China, Italy and Japan to treat the COVID-19 virus. It has shown promising results.” The Hyderabad-based CSIR-IICT has developed a convenient and cost-effective synthetic process for favipiravir, it was announced. Cipla will conduct the investigations before launch of this drug against COVID-19 in India. The pharma company approached regulatory authority DCGI for approval for favipiravir to be launched in India, and under ICMR, it will conduct a suitable limited trial before marketing the product as Ciplenza.

Covid-19: Bengaluru hospital introduces robots to screen people to protect doctors from being infected
India Today- Nolan Pinto

A Bengaluru-based hospital has decided to use advance technology to screen Covid-19 patients before they meet a human doctor. The development comes at a time when doctors, medics across the country have been infected with Covid-19 while screening patients, resulting in shutting of hospitals. At the Fortis Hospital in Bengaluru, Karnataka, robots will now do the initial screening work, which was earlier done by doctors. Mitra and Mitri robots screen people who came to the hospital for Covid-19 check-ups. Mitra robot's job is simple. It asks 5 questions -- your name to telephone number. It also takes the person's body temperature and asks if the person is suffering from fever. Thereafter, it will ask the person if he/she is patient. If it is satisfied with all the details, it will send the person to meet a human being at the reception. However, if the person has been suspected of Covid-19 complications, it will direct him/her to Mitri robot. The second robot screens for Covid-19 and flu-like symptoms, arranges a video call with the doctor and then issues a slip to the patient to visit doctor. Dr (Wing Commander) A Nagasubramaniam, Medical Director, Fortis Hospital, Bannerghatta Road said that the hospital has taken this step to ensure that health care workers are protected in the beginning itself.

New Covid symptoms in Indian patients? Experts need more data
Mint- IANS

The initial symptoms of novel coronavirus disease were identified as Influenza like and respiratory problems till now, but recently the Centre for Disease Control and Prevention, the US agency charged with tracking and investigating public health trends, has come up with new symptoms of novel coronavirus. These new symptoms include symptoms like chills, repeated shaking with chills, headache, muscle pain, loss of taste and smell. Some experts say the new symptoms have been observed in Indian patients too while others have maintained that no such study in India has been published yet and it requires more evidence and data for this conclusion. Speaking to IANS, Senior Resident of Infectious Diseases department of All India Institute of Medical Sciences, New Delhi, Dr Soumyadip Chatterji said, "Yes, we are getting patients with these complaints." Dr Cahtterji explained that people having complaints of loss of smell feel very irritated. "Anosmia is very irritating for patients. Anosmia is loss of smell." Dr Chatterji, who is currently posted at AIIMS dedicated COVID centre in Jhajjar, Haryana, told IANS that such symptoms in Indian COVID patients were visible since the end of March. "As the number of patients increased here in India, we found these symptoms in Indian patients too. I recently encountered an aged diabetic who was unable to take food as he had loss of taste and smell," said Dr Chatterji.